Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Not Yet Recruiting

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05055791

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

NCT04658004

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia

NCT04599543

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02971397

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome

NCT03672539

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Chronic Disease, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

NCT03836209

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

University of California, San Francisco-Fresno (University Oncology Associates) Clovis, California, United States

UCLA Los Angeles, California, United States

Kaiser Permanente Oakland Oakland, California, United States

View all 44 locations

View Trial Details

Completed

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

NCT03374332

Conditions: Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations: Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia

NCT03455504

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ematologia - ASST Papa Giovanni XXIII Bergamo, Italy

Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia Bologna, Italy

Spedali Civili - Azienda Ospedaliera U.O. Ematologia Brescia, Italy

Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy

View all 22 locations

View Trial Details

Completed

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

NCT02071901

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +33 more
Locations: Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions